Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;42(3):266-280.
doi: 10.1111/scd.12669. Epub 2021 Nov 18.

Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review

Affiliations

Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review

Rebeca Barros Nascimento et al. Spec Care Dentist. 2022 May.

Abstract

Aims: Multisystemic inflammatory syndrome in children (MIS-C) is a condition noted in some children asymptomatic but positive to Sars-cov-2 antibody and it presents clinical and laboratory changes similar to Kawasaki disease (KD). Oral changes have also been observed. This systematic review evaluated oral manifestations detected in children with MIS-C and KD associated to COVID-19.

Methods and results: This work was registered at PROSPERO (#CRD42020225909), following PRISMA guidelines. A comprehensive research was conducted in MEDLINE, Web of Science, EMBASE, LILACS, Scopus, and Grey Literature through August 2021, based on original research evaluating children diagnosed with MIS-C or KD related to COVID-19. Two authors independently screened all retrieved references. Twenty five selected studies evaluated 624 children, mean age 8.78 years. The assessment of the risk of bias (ROB) showed that most of them presented low ROB. Oral manifestations were erythematous mucous membrane, oral ulcers lesions, dry, swollen and cracked lips, and strawberry tongue.

Conclusion: MIS-C and KD share the same oral manifestations and their identification may lead to an early diagnosis.

Keywords: COVID-19; Kawasaki disease; multisystem inflammatory syndrome in children; oral manifestations; pediatric multisystem inflammatory syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declared that there is no conflict of interest. No financial or non‐financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Figures

FIGURE 1
FIGURE 1
Flow chart of review conduction

References

    1. Riphagen S, Gomez X, Gonzalez‐Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID‐19 pandemic. Lancet. 2020;395(10237):1607‐1608. - PMC - PubMed
    1. Carter MJ, Shankar‐Hari M, Tibby SM. Paediatric inflammatory multisystem syndrome temporally‐associated with SARS‐CoV‐2 infection: an overview. Intensive Care Med. 2020;47(1):90–93. - PMC - PubMed
    1. Yozgat CY, Uzuner S, Bursal Duramaz B, et al. Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID‐19 in a 3‐year‐old girl. Dermatol Ther. 2020;33(4):e13770. - PMC - PubMed
    1. Spencer R, Closson RC, Gorelik M, et al. COVID‐19 inflammatory syndrome with clinical features resembling kawasaki disease. Pediatrics. 2020;146(3):e2020184. - PubMed
    1. Licciardi F, Pruccoli G, Denina M, et al. SARS‐CoV‐2‐Induced Kawasaki‐like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 2020; 146(2):e20201711. - PubMed

Publication types

MeSH terms

Supplementary concepts